相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anti-Enterovirus 71 Effects of Chrysin and Its Phosphate Ester
Jianmin Wang et al.
PLOS ONE (2014)
Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide
Ying-Ju Lin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Chebulagic Acid, a Hydrolyzable Tannin, Exhibited Antiviral Activity in Vitro and in Vivo against Human Enterovirus 71
Yajun Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Recent Advances in the Discovery and Development of Marine Microbial Natural Products
Zhi-Qiang Xiong et al.
MARINE DRUGS (2013)
Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection
Rui-Yuan Cao et al.
PLOS ONE (2013)
Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo
Yajun Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
CD4 T-Cell-Independent Antibody Response Reduces Enterovirus 71 Lethality in Mice by Decreasing Tissue Viral Loads
Li-Chiu Wang et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Antiviral Effect of Matrine against Human Enterovirus 71
Yajun Yang et al.
MOLECULES (2012)
Daphne Genkwa Sieb. et Zucc. Water-Soluble Extracts Act on Enterovirus 71 by Inhibiting Viral Entry
Chia-Wen Chang et al.
VIRUSES-BASEL (2012)
Survey of Enterovirus Infections from Hand, Foot and Mouth Disease Outbreak in China, 2009
Fan Yang et al.
VIROLOGY JOURNAL (2011)
Developments towards antiviral therapies against enterovirus 71
Kan X. Wu et al.
DRUG DISCOVERY TODAY (2010)
Combined peptides of human enterovirus 71 protect against virus infection in mice
Jiang Ning Liu et al.
VACCINE (2010)
Desferrioxamine as Immunomodulatory Agent During Microorganism Infection
A. Williams et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Lymphocyte and Antibody Responses Reduce Enterovirus 71 Lethality in Mice by Decreasing Tissue Viral Loads
Yu-Wen Lin et al.
JOURNAL OF VIROLOGY (2009)
Iron chelation as therapy for HIV and Mycobacterium tuberculosis co-infection under conditions of iron overload
Debra Meyer
CURRENT PHARMACEUTICAL DESIGN (2006)